검색어: serum ferritin (영어 - 몰타어)

serum ferritin increased
Żieda ta' ferritin fis-serum

a fall in serum ferritin values
- pazjenti anemiċi b’ insuffiċjenza kronika tal- kliewi

the need to monitor serum ferritin monthly
il-bżonn li ferritin fis-serum ikun monitorat kull xahar

saturation and serum ferritin, should be evaluated.
is- saturazzjoni ta ’ transferrin għandha tkun mill - inqas 20%, u dik ta ’ ferritin għandha tkun mill- inqas 100 ng/ ml.

it is recommended that serum ferritin be monitored every month.
huwa rrakkomandat li l-ferritin fis-serum jiġi ċċekkjat kull xahar.

serum ferritin was chosen as the primary efficacy criterion in the studies.
il- ferritin fis- serum intgħażel bħala l- kriterju primarju ta ’ l- effikaċja fl- istudji.

fexeric should be temporarily discontinued if serum ferritin exceeds 800 ng/ml.
fexeric għandu jitwaqqaf temporanjament jekk il-ferritin fis- serum jaqbeż 800 ng/ml.

the rules for stopping when target liver iron concentration and serum ferritin are reached
ir-regoli sabiex jitwaqqaf meta tintlaħaq il-konċentrazzjoni mixtieqa ta’ ħadid fil- fwied u ta’ ferritin fis-serum

a fall in serum ferritin values is very common (see section 4.4).
tnaqqis fil-valuri ta’ ferritin fis-serum huwa komuni ħafna (ara sezzjoni 4.4).

interruption of therapy with deferiprone should be considered if serum ferritin falls below 500 g/l.
għandu jiġi kkonsidrat li t-terapija b’deferiprone titwaqqaf, jekk il-ferritin fis-serum jaqa’ taħt 500 μg/l.

a warning on the necessity of closer monitoring of liver iron concentration and serum ferritin in the paediatric population
twissija dwar il-ħtieġa ta’ monitoraġġ aktar mill-qrib tal-konċentrazzjoni ta’ ħadid fil-fwied u ta’ ferritin fis-serum fil-popolazzjoni pedjatrika

interruption of therapy with deferiprone should be considered if serum ferritin measurements fall below 500 μ g/ l.
il- waqfien tat- terapija b’ deferiprone għandu jiġi kkunsidrat jekk il- kejl tal- ferritin fis- serum jaqa ’ taħt il- 500 μg/ l.

patients) is recommended for chronic renal failure patients whose serum ferritin levels are below 100 ng/ ml
pazjenti pedjatriċi) huwa rakkomandat għal pazjenti b’ insuffiċjenza kronika tal- kliewi kronika li l- livelli ta ’ ferritin fis- serum tagħhom huma taħt 100 ng/ ml sostituzzjoni orali tal- livell ta ’ ferritin ta ’ 200 - 300 mg fe2+/ jum huwa rakkomandat għal

16 the results of the tests for serum creatinine, serum ferritin and serum transaminases should be recorded and regularly assessed for trends.
ir- riżultati tat- testijiet għall- krejatinina fis- serum, ferritin fis- serum u transaminase fis- serum għandhom jinżammu u jintużaw sabiex joħorġu t- tendenzi.

the patient’s serum ferritin should be monitored during and after the combination, and the dose of exjade adjusted if necessary.
il-ferritin fis-serum tal-pazjent għandu jkun monitorat waqt u wara li jingħataw iż-żewġ mediċini, u d-doża ta’ exjade mibdula jekk ikun hemm bżonn.

concurrent use of iron chelators is not recommended in patients whose serum ferritin falls below 500 µg/l due to the risk of excessive iron removal.
l-użu fl-istess waqt ta’ kelaturi tal-ħadid mhux irrakkomandat f’pazjenti li l-livell ta’ ferritin fis-serum jaqa’ għal inqas minn 500 µg/l minħabba r-riskju ta’ tneħħija eċċessiva ta’ ħadid.

supplementary iron therapy is recommended for all patients with serum ferritin values below 100 µg/ l or whose transferrin saturation is below 20%.
199 kura supplementari bil- ħadid hija rakkomandata għall- pazjenti kollha b 'livelli ta ’ ferritin fis- serum taħt 100 μg/ l jew li għandhom saturazzjoni ta ’ transferrin taħt 20%.

if serum ferritin falls consistently below 500 µg/l, an interruption of treatment should be considered (see section 4.4).
jekk il-livelli ta’ ferritin fis-serum jaqaw taħt 500 µg/l b’mod konsistenti, wieħed għandu jqis li jwaqqaf il-kura għal kollox (ara sezzjoni 4.4).

monthly monitoring of serum ferritin is recommended in order to assess the patient’s response to therapy (see section 4.2).
monitoraġġ kull xahar tal-ferritin fis-serum huwa rakkomandat sabiex ikun stmat ir-rispons tal-pazjent għat-terapija (ara sezzjoni 4.2).

daily doses of 10 mg/ kg for one year could maintain liver iron and serum ferritin levels and induce net iron balance in patients receiving infrequent transfusions or exchange transfusions.
pazjenti li kienu qed jirċievu trasfużjonijiet mhux frekwenti jew trasfużjonijiet ta ’ tibdil tad- demm u li ngħataw dożi ta ’ 10 mg/ kg kuljum għal sena, żammew il- livelli ta ’ ħadid fil- fwied u ta ’ ferritin fis- serum u wasslu għal bilanċ nett tal- ħadid.